INDXX MICROSECTORS™ NORTH AMERICAN CANNABIS INDEX COMPONENTS*
The Indxx MicroSectors™ North American Cannabis Index is designed to track the performance of companies that provide products or services related to the medical or industrial use of cannabis or cannabis related products. The Index includes a quarterly IPO review for new issuances and a quarterly review for stocks facing potential regulatory bars to engaging in the cannabis industry. The Index selects constituents from five key sub-themes: Cultivator, Pharmaceuticals, Testing & Analytics, Industrial Hemp, and Ancillary. Companies are screened as either pure play or quasi play, depending on the percentage of revenue that is derived from cannabis or cannabis related products.
WHAT IS THE CANNABIS INDEX?
*Index rebalances monthly. Components as of 7/1/2020
4.72% Canopy Growth
3.97% Innovative Industrial Properties
3.41% Arena Pharmaceuticals
1.98% Aurora Cannabis
0.83% Cara Therapeutics
0.75% Cronos Group
9.90% Agilent Technologies
9.90% Thermo Fisher Scientific
9.90% Waters Corp
5.71% Scotts Miracle-Gro
Source: Bloomberg L.P. Data from 12/15/2017 to 08/31/2020. Past performance does not guarantee future results. The Indxx MicroSectors™ North American Cannabis Index was created by Indxx, LLC in 2019 and was launched on 11/8/2019. Index data prior to that date is hypothetical and reflects the application of the index methodology in hindsight. The hypothetical data cannot completely account for the impact of financial risk in actual trading. Past historical or hypothetical data is not a guarantee of future Index performance. See “Use of Hypothetical Back-Tested Data” in this document.